IVF Jumps 36.6% as EPS Revision Screener Catches Early Signal
INVO Fertility (IVF) led gains with a 36.6% jump to $2.50 after our screener flagged its 98.6% next-year EPS growth on November 2. Granite Ridge (GRNT) rose 29.1% to $6.03 on a strong earnings beat and upward EPS revision, while Wolfspeed (WOLF), Optimum (OPTU), and Vericel (VCEL) each gained over 28% as estimate revisions and catalysts drove price confirmation.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| IVF | Healthcare | 2026-11-02 | N/A | +36.6% |
| GRNT | Energy | 2026-11-05 | +7.3pp | +29.1% |
| WOLF | Technology | 2026-11-05 | N/A | +28.8% |
| OPTU | Communication Services | 2026-11-05 | N/A | +28.1% |
| VCEL | Healthcare | 2026-11-04 | N/A | +28.1% |
Why did IVF stock jump in November 2026?
IVF jumped 36.6% (from $1.83 to $2.50) after our screener detected its 98.6% next-year EPS growth estimate on November 2, 2026.
The healthcare sector has been favoring small-cap fertility names with strong growth profiles, and IVF's estimate reflects that trend. With no company-specific earnings news in the window, the move appears to be driven by algorithmic and momentum buying following the screener detection, as the market confirmed the revision with a sharp price gain.
IVF EPS revision history → · Screener snapshot from 2026-11-02 →
FAQ: IVF
Why did $IVF stock jump?
$IVF jumped 36.6% from $1.83 to $2.50 after our EPS revision screener flagged its 98.6% next-year EPS growth estimate on November 2, 2026.
Is $IVF a buy after the rally?
The stock is up 36.6% since detection, and while the 98.6% EPS growth estimate is compelling, the lack of company-specific news means the rally is momentum-driven and may be volatile.
What is $IVF's EPS growth estimate?
$IVF has a current next-year EPS growth estimate of 98.6%, according to our screener data as of November 2, 2026.
Why did GRNT stock jump in November 2026?
GRNT jumped 29.1% (from $4.67 to $6.03) after analysts raised its next-year EPS growth estimate from 75.2% to 82.4% on November 5, 2026.
The revision followed a strong Q3 earnings beat on November 6, with adjusted EPS of $0.17 topping the $0.13 consensus by 30.8% and revenue of $177.2 million beating estimates by 12.0%. While a third LOE guidance hike tempered the story, the free-cash-flow inflection and record adjusted EBITDAX of $107.3 million reinforced the bullish case. The market confirmed the revision with a sharp price gain, driven by the earnings beat and upward estimate momentum.
GRNT EPS revision history → · Screener snapshot from 2026-11-05 →
FAQ: GRNT
Why did $GRNT stock jump?
$GRNT jumped 29.1% from $4.67 to $6.03 after analysts raised its next-year EPS growth estimate from 75.2% to 82.4% on November 5, 2026, followed by a strong Q3 earnings beat.
What caused $GRNT's surge?
The surge was driven by a 30.8% EPS beat ($0.17 vs. $0.13 consensus) and a 12.0% revenue beat ($177.2M vs. $158.2M) on November 6, which reinforced the upward EPS revision.
What is $GRNT's EPS growth estimate?
$GRNT's next-year EPS growth estimate was revised upward to 82.4% from 75.2% on November 5, 2026.
Why did WOLF stock jump in November 2026?
WOLF jumped 28.8% (from $20.36 to $26.23) after our screener detected its 27.2% next-year EPS growth estimate on November 5, 2026.
The revision followed a fiscal Q1 report on November 4 that, despite an EPS miss, featured higher revenue guidance, a near-breakeven margin outlook, and a conditional $1.5 billion government loan. The semiconductor sector's recovery hopes and Wolfspeed's improved gross margin trend (up 710 basis points sequentially) provided additional support. The market focused on the forward-looking improvements and the loan's potential to replace expensive debt, driving the stock higher.
WOLF EPS revision history → · Screener snapshot from 2026-11-05 →
FAQ: WOLF
Why did $WOLF stock jump?
$WOLF jumped 28.8% from $20.36 to $26.23 after our screener detected its 27.2% next-year EPS growth estimate on November 5, 2026, following a Q1 report with higher revenue guidance and a conditional $1.5B loan.
What caused $WOLF's surge?
The surge was driven by Wolfspeed's higher revenue guidance, a near-breakeven margin outlook, and a conditional $1.5 billion government loan that would replace its most expensive debt, announced on November 4, 2026.
What is $WOLF's EPS growth estimate?
$WOLF has a current next-year EPS growth estimate of 27.2%, as detected by our screener on November 5, 2026.
Why did OPTU stock jump in November 2026?
OPTU jumped 28.1% (from $0.57 to $0.73) after our screener detected its 86.9% next-year EPS growth estimate on November 5, 2026.
The company announced on November 4 that it would report Q3 2026 results through Form 10-Q on November 6 without a conference call, as it pursues a consensual restructuring of its capital structure. The communication services sector has seen volatility, but OPTU's high growth estimate and restructuring efforts attracted buyers. The lack of a call suggests the company is focusing on the restructuring, and the market may be anticipating a favorable outcome.
OPTU EPS revision history → · Screener snapshot from 2026-11-05 →
FAQ: OPTU
Why did $OPTU stock jump?
$OPTU jumped 28.1% from $0.57 to $0.73 after our screener detected its 86.9% next-year EPS growth estimate on November 5, 2026, as the company pursues a capital restructuring.
Is $OPTU a buy after the rally?
The stock is up 28.1% since detection, but the ongoing restructuring and lack of an earnings call add uncertainty; the 86.9% EPS growth estimate is a positive signal, but risks remain.
What is $OPTU's EPS growth estimate?
$OPTU has a current next-year EPS growth estimate of 86.9%, according to our screener data as of November 5, 2026.
Why did VCEL stock jump in November 2026?
VCEL jumped 28.1% (from $45.48 to $58.24) after our screener detected its 61.9% next-year EPS growth estimate on November 4, 2026.
The revision was validated by a strong Q3 beat on November 5, with EPS of $0.27 versus $0.02 consensus (1,250% surprise) and revenue of $85.4 million beating estimates by 9.0%. Management raised full-year revenue guidance for the third straight quarter to $344-$346 million and lifted its adjusted EBITDA margin target to 28%. The healthcare sector's focus on high-growth medtech and Vericel's reaccelerating growth (26% vs. 22% in Q2) drove the stock higher.
VCEL EPS revision history → · Screener snapshot from 2026-11-04 →
FAQ: VCEL
Why did $VCEL stock jump?
$VCEL jumped 28.1% from $45.48 to $58.24 after our screener detected its 61.9% next-year EPS growth estimate on November 4, 2026, followed by a massive Q3 earnings beat and raised guidance.
What caused $VCEL's surge?
The surge was driven by a 1,250% EPS surprise ($0.27 vs. $0.02 consensus) and a 9.0% revenue beat ($85.4M vs. $78.3M) on November 5, along with raised full-year revenue and EBITDA margin guidance.
What is $VCEL's EPS growth estimate?
$VCEL has a current next-year EPS growth estimate of 61.9%, as detected by our screener on November 4, 2026.
Today's top performers highlight the market's receptiveness to upward EPS revisions, especially when backed by strong earnings beats and strategic developments. The gains across healthcare, energy, and technology suggest that estimate revision momentum is a powerful driver of short-term price action, with investors rewarding companies that demonstrate growth and operational improvements.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →